Viewing Study NCT06989359


Ignite Creation Date: 2025-12-24 @ 2:53 PM
Ignite Modification Date: 2025-12-25 @ 1:19 PM
Study NCT ID: NCT06989359
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-06-10
First Post: 2025-05-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease
Sponsor: ADARx Pharmaceuticals, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module